NCT05172245 2026-03-18
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
National Cancer Institute (NCI)
City of Hope Medical Center
Centre Antoine Lacassagne
M.D. Anderson Cancer Center
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Dana-Farber Cancer Institute
MediLink Therapeutics (Suzhou) Co., Ltd.